Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.

Detalhes bibliográficos
Main Authors:	Hennekens, C, Buring, J, Sandercock, P, Collins, R, Peto, R
Formato:	Journal article
Idioma:	English
Publicado em:	1989

Registos relacionados

Aspirin and stroke.
Por: Buring, J, et al.
Publicado em: (1990)

ASPIRIN USE AND CHRONIC DISEASES
Por: Hennekens, C, et al.
Publicado em: (1990)

Aspirin in ischemic heart disease.
Por: Hennekens, C, et al.
Publicado em: (1992)

Low-dose aspirin for migraine prophylaxis.
Por: Buring, J, et al.
Publicado em: (1990)

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
Por: Baigent, C, et al.
Publicado em: (2009)

Antioxidant vitamins, cancer, and cardiovascular disease - Reply
Por: Hennekens, C, et al.
Publicado em: (1996)

Antiplatelet agents in stroke prevention.
Por: Peto, R
Publicado em: (1988)

Aspirin in the primary prevention of vascular disease Reply
Por: Baigent, C, et al.
Publicado em: (2009)

Aspirin in the primary prevention of vascular disease Reply
Por: Baigent, C, et al.
Publicado em: (2009)

Prevention. Aspirin in primary prevention--good news and bad news.
Por: Hennekens, C, et al.
Publicado em: (2012)

Prevention: Aspirin in primary prevention-good news and bad news
Por: Hennekens, C, et al.
Publicado em: (2012)

Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomised trials. Antiplatelet Trialists' Collaboration.
Por: Collins, R, et al.
Publicado em: (1994)

TRIALS OF ANTIPLATELET THERAPY - REPLY
Por: Baigent, C, et al.
Publicado em: (1994)

Polypills with or without aspirin for primary prevention of cardiovascular disease
Por: Mant, J, et al.
Publicado em: (2021)

Role of aspirin in primary prevention of cardiovascular disease
Por: Patrono, C, et al.
Publicado em: (2019)

Aspirin overutilization for the primary prevention of cardiovascular disease
Por: VanWormer JJ, et al.
Publicado em: (2014-12-01)

Aspirin for primary prevention of cardiovascular disease in diabetes
Por: Ying Xing, et al.
Publicado em: (2019-07-01)

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
Publicado em: (2005-12-01)

Underutilization of aspirin persists in US ambulatory care for the secondary and primary prevention of cardiovascular disease.
Por: Randall S Stafford, et al.
Publicado em: (2005-12-01)

Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease
Por: Guillaume Marquis‐Gravel, et al.
Publicado em: (2024-02-01)

An overview of the British and American aspirin studies.
Por: Hennekens, C, et al.
Publicado em: (1988)

Sex-related differences in response to aspirin in cardiovascular disease: an untested hypothesis.
Por: Hennekens, C, et al.
Publicado em: (2006)

PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE AND ANTIPLATELET THERAPY. CLINICAL LECTURE
Por: L. O. Minushkina
Publicado em: (2017-12-01)

Which people should take aspirin for primary prevention of cardiovascular disease?
Por: Lozano R, et al.
Publicado em: (2015-07-01)

Misuse of Aspirin and Associated Factors for the Primary Prevention of Cardiovascular Disease
Por: Yinong Chen, et al.
Publicado em: (2021-09-01)

Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain
Por: Fernández-de-Bobadilla Jaime, et al.
Publicado em: (2007-10-01)

Use and Misuse of Aspirin in Primary Cardiovascular Prevention
Por: Sergio Coccheri
Publicado em: (2017-04-01)

Antiplatelet treatment in primary and secondary stroke prevention in women.
Por: Caso, V, et al.
Publicado em: (2012)

Antiplatelet treatment in primary and secondary stroke prevention in women
Por: Caso, V, et al.
Publicado em: (2012)

Low-dose aspirin for primary and secondary prevention of cardiovascular events in Denmark 1998–2018
Por: Mikkel B. Christensen, et al.
Publicado em: (2021-06-01)

Primary prevention of cardiovascular events in diabetes: is there a role for aspirin?
Por: Price, H, et al.
Publicado em: (2009)

Aspirin for prevention of cancer and cardiovascular disease.
Por: Rose, P, et al.
Publicado em: (2011)

Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?
Por: Patrono, C, et al.
Publicado em: (2010)

Aspirin strategy for secondary prevention of atherosclerotic cardiovascular diseases: A narrative review
Por: Nischal N Hegde, et al.
Publicado em: (2023-01-01)

Role of aspirin in the primary prevention of cardiovascular disease in patients with hyperlipoproteinaemia(a)
Por: Eleni Giannopoulou, et al.
Publicado em: (2024-12-01)

US population qualifying for aspirin use for primary prevention of cardiovascular disease
Por: Athena L. Huang, et al.
Publicado em: (2024-06-01)

US POPULATION QUALIFYING FOR ASPIRIN USE FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE:
Por: Athena L. Huang, MD, et al.
Publicado em: (2023-09-01)

DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT
Por: N. В. Perepech, et al.
Publicado em: (2018-05-01)

Antiplatelets in secondary stroke prevention
Por: Olga eShulga, et al.
Publicado em: (2011-07-01)

Antioxidant vitamins--benefits not yet proved.
Por: Hennekens, C, et al.
Publicado em: (1994)